Patterning mechanisms of the sub-intestinal venous plexus in zebrafish  by Goi, Michela & Childs, Sarah J.
Developmental Biology 409 (2016) 114–128Contents lists available at ScienceDirectDevelopmental Biologyhttp://d
0012-16
n Corr
E-mjournal homepage: www.elsevier.com/locate/developmentalbiologyPatterning mechanisms of the sub-intestinal venous plexus in
zebraﬁsh
Michela Goi, Sarah J. Childs n
Department of Biochemistry and Molecular Biology and Alberta Children's Hospital Research Institute, University of Calgary, 3330 Hospital Drive NW,
Calgary, AB, Canada T2N 4N1a r t i c l e i n f o
Article history:
Received 23 February 2015
Received in revised form
5 October 2015
Accepted 12 October 2015
Available online 22 October 2015
Keywords:
Zebraﬁsh
Vein
Sub-intestinal venous plexus
Vegf
Bmp
PlexinD1x.doi.org/10.1016/j.ydbio.2015.10.017
06/& 2015 Elsevier Inc. All rights reserved.
esponding author.
ail address: schilds@ucalgary.ca (S.J. Childs).a b s t r a c t
Despite considerable interest in angiogenesis, organ-speciﬁc angiogenesis remains less well character-
ized. The vessels that absorb nutrients from the yolk and later provide blood supply to the developing
digestive system are primarily venous in origin. In zebraﬁsh, these are the vessels of the Sub-intestinal
venous plexus (SIVP) and they represent a new candidate model to gain an insight into the mechanisms
of venous angiogenesis. Unlike other vessel beds in zebraﬁsh, the SIVP is not stereotypically patterned
and lacks obvious sources of patterning information. However, by examining the area of vessel coverage,
number of compartments, proliferation and migration speed we have identiﬁed common developmental
steps in SIVP formation. We applied our analysis of SIVP development to obd mutants that have a mu-
tation in the guidance receptor PlexinD1. obd mutants show dysregulation of nearly all parameters of
SIVP formation. We show that the SIVP responds to a unique combination of pathways that control both
arterial and venous growth in other systems. Blocking Shh, Notch and Pdgf signaling has no effect on
SIVP growth. However Vegf promotes sprouting of the predominantly venous plexus and Bmp promotes
outgrowth of the structure. We propose that the SIVP is a unique model to understand novel mechanisms
utilized in organ-speciﬁc angiogenesis.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Organ-speciﬁc regulation of sprouting, migration, proliferation
and vascular network establishment during angiogenesis is one of
the less well understood aspects of vascular development (Geu-
dens and Gerhardt, 2011). One important role of the vascular
system is to deliver nutrients acquired from the mother, or from
absorption from the digestive system, to tissues and organs. To do
so, blood vessels need to be in close contact with embryonic nu-
trient sources. In the adult, digestive system vessels need to be
organized in highly efﬁcient vascular networks.
Here, we focus on the development of vessels in the sub-in-
testinal venous plexus (SIVP), a set of predominantly venous an-
giogenic vessels that initially obtain nutrients from the yolk and
transfer them to the developing embryo body through the ad-
jacent yolk syncytial layer (YSL), and that will later support the
distribution of blood to the digestive system in the larva and adult
ﬁsh (reviewed in Carvalho and Heisenberg, 2010; Donovan et al.,
2000). The developing sub-intestinal venous plexus (SIVP) has
been used as an easily visible vascular bed to screen for moleculesthat inﬂuence angiogenesis including pro- or anti-angiogenic fac-
tors (Chan et al., 2012; Kuo et al., 2011; Nicoli et al., 2009, 2007;
Nicoli and Presta, 2007; Raghunath et al., 2009; Serbedzija et al.,
1999). However, the study of the effects of these molecules is
limited by poor knowledge of SIVP development, including whe-
ther or not this venous plexus is similar to other vascular beds in
its development.
Little is known about early development of visceral vasculature
in any animal model system but an anatomical atlas suggests that
in zebraﬁsh the supraintestinal artery (SIA) that delivers blood,
and the bilateral sub-intestinal veins that collect the blood from
the digestive system, start to develop around 2 dpf (Isogai et al.,
2001). The SIVP is suggested to sprout from the duct of Cuvier
(future common cardinal vein) and connect to the posterior car-
dinal vein (PCV) (Isogai et al., 2001; Nicoli and Presta, 2007).
Around 3 dpf, the SIVP which has extended on the large surface of
the yolk ball, appears as a vascular basket with compartments
delimited by veins. The most anterior part of the right and left
SIVPs drain into the hepatic sinusoids of the liver through the two
hepatic portal veins. At 4 dpf, with the reduction of yolk size as the
embryo feeds on it, the left SIVP starts regressing and empties into
the right SIVP. Later, the blood from the posterior gut will only use
the right SIVP to reach the liver (Isogai et al., 2001). Given that this
plexus vascularizes essential visceral organs, gross defects in SIVP
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Extrinsic cues and intrinsic receptors guide the morphogenesis
of the vascular system. Vascular endothelial growth factor A
(VegfA) induces endothelial cell proliferation and migration while
inhibiting apoptosis (Carmeliet et al., 1996; Liang et al., 2001;
Shalaby et al., 1995). During intersegmental vessel (ISV) angio-
genesis, vegfA is expressed mid-somite around the notochord in a
gradient to attract the sprouting vessels while its receptor (vas-
cular endothelial growth factor receptor 2, vegfr2) is expressed by
the angioblasts (Fouquet et al., 1997). In the zebraﬁsh, vegfA ex-
pression is induced by sonic hedgehog (shh) expression at the
midline (Lawson et al., 2002). Together with Vegf, Notch signaling
is necessary for arterial speciﬁcation in the trunk, and for the
decision to take on a tip (migratory, proliferative) or stalk (non-
migratory, non-proliferative) identity in the developing interseg-
mental arteries of the zebraﬁsh embryo (Siekmann and Lawson,
2007). Platelet-derived growth factor (Pdgf) signaling has also
been reported to induce ISV sprouting (Wiens et al., 2010).
Venous sprouting can be easily studied in the ﬁsh as it is clearly
visible in real time. Venous ISVs form through cellular emigration
from the PCV (Isogai et al., 2003; Yaniv et al., 2006) to connect
with the arterial ISVs and require VegfC/Flt4 signaling. vegfC ligand
is expressed in the dorsal aorta (DA) and its receptor ﬂt4 (vegfr3) in
the sprouting cells of the vein (Covassin et al., 2006; Hogan et al.,
2009a, 2009b). Bone morphogenetic protein (Bmp) is an im-
portant cue for venous migration ventrally during formation of the
caudal venous plexus (CVP). Interestingly, VegfA is not required for
CVP sprouting suggesting a difference between arterial and venous
sprouting in the formation of this bed (Wiley et al., 2011). Venous
sprouting of the CVP is also sensitive to perturbation in prenyla-
tion (Choi et al., 2011) and Sphingosine-1-phosphate signaling. The
S1P1 receptor is expressed in endothelial cells and inhibits ﬁlo-
podia formation to stabilize the vascular network. Absence or re-
duction of S1P1 in the CVP causes excessive ﬁlopodial extensions
resulting in a fused plexus instead of the wild-type honeycomb-
like structure (Ben Shoham et al., 2012; Mendelson et al., 2013). A
third example of venous sprouting can be found in formation of
the common cardinal veins which occurs by lumen ensheathment
and is sensitive to vegfC levels (Helker et al., 2013). These examples
highlight diverse mechanisms and cues for venous sprouting in
different organs. Here we characterize the sprouting of a fourth
venous bed the SIVP and ﬁnd signiﬁcant differences in the cues
and morphology of its development to other venous beds.
Only a few mutants show growth defects in the SIVP. out of
bounds (obd) mutants have a mutation in the angiogenic guidance
receptor plexinD1 and an overgrown SIVP (Childs et al., 2002). obd
ISVs also show disrupted control of timing and direction of an-
gioblast migration from the dorsal aorta and an altered and
overgrown caudal vein plexus (Childs et al., 2002; Torres-Vazquez
et al., 2004). Plexins are transmembrane semaphorin (Sema) re-
ceptors that provide guidance for migrating angioblasts, axonal
guidance and pruning, sensory-motor circuit connectivity and
immune system development (Gay et al., 2011). A model for Sema-
PlexinD1 signaling suggests that integrin based adhesion is lost
when PlexinD1 receptor is activated by ligand causing retraction of
ﬁlopodia and cellular detachment from the extracellular matrix,
thus restricting migration (Sakurai et al., 2010). In the trunk, sema3
ligands are expressed in the somites and plexinD1 in the en-
dothelium. plexinD1 expressing angioblasts receive a repulsive
signal when they contact the somite thus limiting their pathway to
the space between somites (Torres-Vazquez et al., 2004; Zygmunt
et al., 2011). Semaphorin-PlexinD1 signaling also has a second
function in promoting delta-like 4 (dll4) expression in tip cells
downstream of VegfA signaling and thereby altering the tip-stalk
cell balance to limit angiogenesis (Kim et al., 2011).
SIVP development is affected by lipoprotein levels. Mutation inthe microsomal triglyceride transfer protein (mtp) causes excessive
angiogenesis in the SIVP resulting in defective yolk absorption.
mtp is expressed in the zebraﬁsh yolk syncytial layer (YSL) and in
the larval/adult gut and is important for the proper production of
ApoB-containing lipoproteins (such as LDLs) that deliver lipids
(Avraham-Davidi et al., 2012; Hussain et al., 2008; Marza et al.,
2005). Low concentrations of lipoproteins decrease levels of sﬂt1,
the soluble Vegfr1 (sFlt1) receptor. Since sFlt1 sequesters VegfA
and therefore decreases signaling through Vegfr2 the end result is
to enhance angiogenic sprouting (Avraham-Davidi et al., 2012;
Kendall and Thomas, 1993; Roberts et al., 2004; Zygmunt et al.,
2011). Interestingly, the intestinal lymphatics also grow in close
relationship with the SIVP, may also have a role in lipid trans-
portation, and may share similar signaling control (Okuda et al.,
2012).
Using live imaging we trace SIVP development in real time. We
ﬁnd that the features of the developing SIVP are not hard-wired as
they are in some other vascular beds of the zebraﬁsh. The SIVP
shows variable patterning among embryos, although we ﬁnd
common developmental morphologies. We identify commonal-
ities in wild-type SIVP development in order to describe SIVP
morphogenesis and apply it to the genetic obd mutants. Small
molecule inhibition of the Vegf, Bmp and Mek/Erk pathways, but
not other signaling pathways used in arterial growth, inhibit the
proper formation of the SIVP. Our results suggest the developing
gut vasculature responds to a unique set of growth factors, and is a
model to shed insight into mechanisms of visceral organ
angiogenesis.2. Materials and methods
2.1. Zebraﬁsh embryos
Embryos were collected and dechorionated through a brief
treatment with pronase (Sigma-Aldrich, St. Louis, MO), incubated
at 28.5 °C in E3 embryo medium and staged in hours post-fertili-
zation (hpf) or days post fertilization (dpf). Endogenous pigmen-
tation was inhibited from 24 hpf by the addition of 0.003%
1-phenyl-2-thiourea (PTU, Sigma-Aldrich) in E3 embryo medium.
The ﬂuorescent transgenic lines Tg(ﬂi:EGFP)y1 (Lawson and Wein-
stein, 2002), Tg(ﬂi:EGFP)y7 (Roman et al., 2002) were used to vi-
sualize cells and nuclei of endothelial cells respectively. out of
bounds homozygous embryos obdfov01b were used in all experi-
ments using mutants (Childs et al., 2002). Morpholino knockdown
(Gene Tools LLC, Corvallis, OR) used the following sequences:
bmp4 (5′-GTCTCGACAGAAAATAAAGCATGGG-3′) (Zeng and Childs,
2012), vegfaa (5′-GTATCAAATAAACAACCAAGTTCAT-3′) (Childs
et al., 2002), vegfab (5′-GGAGCACGCGAACAGCAAAGTTCAT-3′)
(Bahary et al., 2007) and plexinD1 (5′-TGAGGGTATTTA-
CAGTCGCTCCGC-3′) (Torres-Vazquez et al., 2004), at doses of 7, 2,
2 and 15.5 ng/embryo respectively.
2.2. Inhibitor treatments
Drug stocks were heated for 20 min at 65 °C and then diluted in
E3 embryo medium and added to embryos from 4 or from 24 hpf.
DMSO (D8418, Sigma) was used as a vehicle and control. Embryos
were grown at 28.5 °C in the dark until imaging. Doses and sources
are listed in Table S1.
2.3. Confocal imaging and measurements
Up to 10 embryos were mounted in 1% low melt agarose (In-
vitrogen) on glass bottom dishes (MatTek, Ashland MA) and im-
aged using a Zeiss LSM700 microscope using ZEN Black 2012
Fig. 1. The SIVP originates from the PCV. (A) Lateral view of a Tg(ﬂi:EGFP)y1 zebraﬁsh embryo at 4 dpf. The SIVP is located on the surface of the yolk. (B) In situ hybridization
with gata6 shows the position of the endoderm/gut (white arrowheads) in comparison to the outer SIVP basket (black arrowheads) at 3 dpf. (C) Analogous mouse om-
phalomesenteric vessels (vitelline veins) of the yolk sac of an E12.5 mouse embryo are indicated by white arrowheads. (D–I′) Single images taken from a time-lapse series
highlight steps in the genesis of the SIVP. Images are shown for the left side of the embryo (D–E). At around 28 hpf, few cells start sprouting from the vein (white arrows).
(F) At 29 hpf, the sprouts start elongating on the yolk ball (white arrows). (G–I) From 31 to 34.5 hpf, the SIVP continues to grow ventrally. (D′–I′Enlargements of embryos in
D–I. (J–L) Schematics corresponding to speciﬁc time-lapse images (D′, F′, H′) that clarify the origin of SIVP vessels. (M–N) 3D images of the developing SIVP show sprouts
emanating from the vein (yellow arrowheads). Scale bars represent 100 mm.
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ered. For time-lapse, z-stacks were acquired every 30 min. ZEN
Blue 2012 software was used for image processing and Fiji
(Schindelin et al., 2012) for depth-coded pseudo-color of the
stacks. For the calculation of area we considered the SIVP space
delimited by veins below the same 5 somites. For the migration
speed we measured the distance to the farthest point of the SIVP
from the PCV at speciﬁc time points. A 2-tailed Student's T-Test or
one way ANOVA test was run using SigmaPlot (Systat Software
Inc., San Jose, CA).
2.4. In situ hybridization, antibody and EdU staining
Embryos were ﬁxed in 4% paraformaldehyde (PFA, Sigma-Al-
drich). Probe templates were produced by PCR ampliﬁcation or
using a plasmid template (Table S2). In situ hybridization was
performed as described (Lauter et al., 2011). GFP was detected
with a 1/500 dilution of anti-GFP antibody (Stratagene-Agilent,
Santa Clara, CA) and by a secondary α-mouse biotin conjugated
antibody and DAB staining (Vectastain, Vector Laboratories, Bur-
lingame, CA). Invitrogen Molecular Probes Click-iT EdU Alexa Fluor
555 Imaging Kit (Eugene, Oregon, USA) was used to mark pro-
liferative cells of the SIVP. EdU was incubated with the embryos for
30 min at 48 hpf. Embryos were mounted in 2% methylcellulose
and were visualized under white light and photographed using a
Stemi SV11 microscope, Axiocam HRc camera and AxioVision or
ZEN Lite 2012 software or with a Zeiss LSM700 confocal micro-
scope (Carl Zeiss Canada Ltd).3. Results
3.1. Structural similarities between the zebraﬁsh sub-intestinal ve-
nous plexus and mouse vitelline veins
The SIVP is a bilateral vascular structure (Fig. 1A and S1) in
direct contact with YSL on the surface of the yolk (Carvalho and
Heisenberg, 2010). The SIVP is therefore likely the vascular struc-
ture that mediates the uptake and circulation of nutrients from
yolk to embryo (Isogai et al., 2001). The SIVP empties into the
hepatic sinusoids of the liver using the two hepatic portal veins
during early development (Isogai et al., 2001). The SIVP also forms
the vascular plexus around the gut (Fig. 1B) that starts to circulate
blood around 3 dpf before the left SIVP starts regressing around
4 dpf. Remodeling occurs so that posterior vessels connect to the
right SIVP, which connects to the liver (Isogai et al., 2001).
The murine equivalent of the SIVP, the omphalomesenteric
vessels (i.e., vitelline veins, Fig. 1C), belong to the extraembryonic
circulation and connect the embryo with the yolk sac, transferring
nutrients from the yolk sac to the circulation. These veins originate
at 8 days post-coitum (dpc) from the blood islands, which are
groups of mesodermal cells inside the yolk sac that form vessels by
vasculogenesis (Kaufman, 1999a). The vitelline veins also initially
provide blood supply to the embryonic digestive system and form
hepatic sinusoids (Crawford et al., 2010; Kaufman, 1999a). At
around 12.5 dpc, the right vitelline vein becomes the portal vein,
which brings blood from the gut and spleen to the liver. The
anterior part of this vein becomes the primitive inferior vena cava,
while the extrahepatic portion of the left vitelline vein regresses
(Crawford et al., 2010; Kaufman and Bard, 1999b). These connec-
tions and functions are similar to the pattern of zebraﬁsh SIVP
vessels.
3.2. The SIVP sprouts from the PCV
To gain insight into the early origin of the SIVP, we ﬁrstexamined its development using confocal microscopy time-lapse
of Tg(ﬂi:EGFP)y1 transgenic embryos (Fig. 1D–F′ and Movie 1). We
ﬁnd that the SIVP ﬁrst vessels start to form before 30 hpf. In
contrast, previous studies using angiography suggested that these
vessels form only at 48 hpf (Isogai et al., 2001) (Fig. 1D–D′). On the
right side of the embryo, SIVP sprouting starts slightly later, giving
rise to a less extensive basket (Fig. S1). Moreover, due to the fact
that the right SIVP does not generate hepatic sinusoids it does not
extend as far anteriorly (Fig. S1) (Isogai et al., 2001), all further
data shown here is from the left side. Instead of seeing initial
sprouts originating from the duct of Cuvier, as previously sug-
gested (Isogai et al., 2001; Nicoli and Presta, 2007), we see
sprouting from the posterior cardinal vein (Fig. 1D–F′, white ar-
rows). 3D reconstructions conﬁrm our observation (Fig. 1M and N).
Anterior and posterior sprouts then migrate towards each other,
join, continue to sprout, and grow ventrally to form a developed
vascular basket above the yolk ball (Fig. 1D–I′) as schematized in
Fig. 1J–L. To support our ﬁnding we analyzed the expression of
arterial and venous markers, however they are not expressed
highly enough in these vessels at this developmental stage to be
informative (Fig. S2). While this paper was under revision, Ni-
cenboim and colleagues suggested that the PCV cell population
gives rise to the SIVP but also also gives rise to the SIA. It is pos-
sible that arteriovenous identity is not fully established in the PCV
at this developmental stage (Nicenboim et al., 2015).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.10.017.
3.3. The SIVP is not stereotypically patterned and has a superﬁcial
and deep plexus
We noticed that individual Tg(ﬂi:EGFP)y1 embryos have differ-
ent SIVP patterns over time, particularly from 2 to 4 dpf (two re-
presentative embryos are shown in Fig. 2). We note that the po-
sition and number of vessels is similar but not precisely the same
(Fig. 2A–A′ and D–D′). This suggests that there is not a strict ste-
reotypical control of the SIVP pattern as observed for the ISVs in
the trunk, but there are physical or molecular patterning cues that
guide the patterning into the basket shape. Moreover, we notice
that the pattern continues to be variable during later development
as the embryos continue to show differences in vessel path and
number, number of compartments, area, and vessel branching
(Fig. 2A–F′). While the early SIVP is superﬁcial and located on the
yolk surface, at 3 dpf there is a second inner vascular basket of
vessels visible (white arrowheads in Fig. 2B–F′) which is connected
to the outer basket through common vessels (red arrowheads in
Fig. 2B', C', E' and F'), highlighted in the schematics (Fig. 2G). These
connections are more apparent at 4 dpf as rendered in depth-co-
ded pseudo-colored stacks (Fig. 2C–C′ and F–F′). Since the inner
basket has close contact with the intestine and the outer basket
regresses during development, we hypothesize that the inner
basket will form the gut vasculature and hepatic sinusoids, while
the external basket may serve to gather nutrition from the yolk in
the early development.
3.4. The SIVP shows common developmental steps instead of a ste-
reotypical pattern
To develop a staging series useful for comparison with mutants
we observed common features of SIVP formation in different
embryos between 30 and 80 hpf (Fig. 3 and Movie 2). At 30 hpf we
see the ﬁrst SIVP vessel along the body of the embryo (Fig. 3A). At
34 hpf we see the sprouting of the ﬁrst SIVP vessel from both di-
rections to make what will become the outer basket (Fig. 3B).
Compartments (deﬁned as vascular honeycomb-shaped struc-
tures) form at around 48 hpf (Fig. 3C). At 55 hpf ﬁlopodia are
Fig. 2. The SIVP vascular pattern is variable among embryos and develops superﬁcial and deep vessel baskets. Depth-coded confocal Z-projections of SIVP development in
two individual embryos (A–C′ and D–F′) from 2 to 4 dpf show a similar organization, but small differences in pattern. (A, D) At 2 dpf, the SIVP appears as a single basket on
the surface of the yolk. (B, E) At 3 dpf a deeper second vascular basket is visible (the border of the inner basket is indicated by white arrowheads). (C, F) This inner basket
becomes more evident at 4 dpf. Some vessels connect both inner and outer vessels (red arrowheads). (A′–F′) Enlargements of images in A–F. (G) Schematics from WT
1 embryo images A–C. Arrowheads indicate the boarder of the inner basket. Scale bars represent 100 mm.
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search as the structure grows ventrally (Fig. 3D). Around 58 hpf
lamellipodia are more prevalent at the leading edge of the ventral
migration (Fig. 3E). Migration continues at 65 hpf (Fig. 3F), and the
continuing expansion of the SIVP on the yolk ball occurs in parallel
with the onset of remodeling and pruning of some vessels (Fig. 3G
and H; blue arrows in F′–H′). These common steps deﬁne a staging
series of SIVP formation (schematized in Fig. 3I) and are useful to
understand developmental restrictions in a vessel bed that does
not have a ‘hard-wired’ pattern.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.10.017.
3.5. Quantiﬁcation of SIVP growth and pattern
We next developed a quantitative metric that describes the
SIVP developmental process and allows meaningful comparison
with mutants. We were careful to control for potentially con-
founding variables in our imaging and analysis. Firstly, each em-
bryo was positioned dorso-laterally in order to obtain stereo-
typical images that were not distorted by the rounded nature of
the yolk ball. Secondly, we used anatomical landmarks, such as the
angle of the right and left dorsal longitudinal anastomotic vessels
(DLAVs) in the anterior part of the trunk, to ensure that the area
captured of different embryos was comparable. By studying a
number of embryos, and analyzing only embryos with an entirely
visible SIVP, we reduced error from these sources.
We calculated the area of vessel coverage at two different
stages, 55 and 80 hpf (Fig. 4A). These stages were chosen because
they are representative of two phases of SIV expansion and de-
velopment, and are in a time window when angiogenic defectsbecome evident in mutants. We measured the area of the SIVP
below the same 5 somites at 55 hpf and obtained a mean area of
35,866 77023 mm2 (n¼18) for the SIVP. At 80 hpf the mean area
reached 56,128 78585 mm2 (n¼23 embryos; Fig. 4A).
To measure migration speed, the farthest extent of migration of
the SIVP outer basket was tracked in 5 embryos from 30 to 80 hpf
in time-lapse and the migration distance was calculated as the
distance to the farthest point of the SIVP at speciﬁc time points
from the posterior cardinal vein (Fig. 4B). We found that the
average speed of migration was as 4.570.6 mm/h. We ﬁnd that
there are an average of 1172.3 (n¼17) vessel compartments
within the SIVP at 55 hpf (Fig. 4C). Using the average SIVP area the
average area of a compartment is 3260 μm2. The number of
compartments could not be calculated for 80 hpf because it was
difﬁcult to resolve individual compartments once inner and outer
baskets developed.
3.6. Both leading and trailing cells proliferate during migration
In mouse retina, stalk cells proliferate but tip cells do not
(Gerhardt et al., 2003) while in zebraﬁsh intersegmental arteries,
tip cells proliferate but not stalk cells (Siekmann and Lawson,
2007). We tracked cell division in the SIVP in time-lapse in in-
dividual Tg(ﬂi:EGFP)y7 embryos, which express the transgene only
in the nuclei of endothelial cells, allowing us to track cell division
events (Movie 3). From 46 to 50 hpf in the SIVP, we ﬁnd pro-
liferation of tip (leading) and stalk (trailing) cells during the ex-
pansion of the vascular basket (Fig. 5). Thus we ﬁnd comparable
cell division throughout the SIVP, with no preference for either tip
or stalk. This conclusion is also supported by EdU staining (Fig. 5I–
K″′).
Fig. 3. Standardized staging series for SIVP development. Representative confocal micrographs of a time-lapse of SIVP development chosen to show common steps between
30 and 76 hpf. (A′–H′) Enlargements of images below each single original frame. (A′) Red arrowheads indicate the sprouts from the PCV. (B′) Red arrows indicate the sprout
from the ﬁrst SIVP vessel connecting with the supraintestinal artery, located along the midline. White arrows indicate the sprouts from the ﬁrst SIVP vessel migrating
ventrally around the yolk. (C′) Yellow arrowheads point to developing compartments. (D′ Yellow arrows mark the presence of ﬁlopodia. (E′) Blue arrowheads show the
formation of lamellipodia. (F′–G′–H′) Blue arrows indicate pruning events. (I) Schematics corresponding to key timepoints (A′, D′, E′ and G′) in the progression of SIVP
development. Scale bars represent 100 mm.
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3.7. obd mutants show excessive SIVP angiogenesis
obd zebraﬁsh develop precocious and spatially unrestricted
arterial ISV sprouts, anomalous angioblast migration, and ectopic
connection among vessels (Childs et al., 2002). Interestingly, the
SIVP also has an anomalous pattern in obd mutants (Fig. 6), sug-
gesting PlexinD1 involvement in SIVP patterning. PlexinD1 is ex-
pressed in SIVP endothelial cells (Fig. S1). Putative PlexinD1 li-
gands are expressed very weakly at this developmental stage in
the yolk region and we could not determine which was likely to be
the PlexinD1 ligand for patterning (Fig. S1). We examined SIVP
formation in obdfov01b; Tg(ﬂi:EGFP)y1 embryos or plexinD1 mor-
phants as compared to wild-type Tg(ﬂi:EGFP)y1 embryos, employ-
ing our wild-type staging series.Confocal microscopy time-lapse of obdmutant embryos reveals
that SIVP patterning is more variable among individual obd mu-
tants than among wild-type embryos (Fig. 6). We observe an in-
creased number of compartments, greater expansion on the yolk
and a higher number of sprouts from the basket in obd mutants.
This suggests that the molecular restrictions establishing a regular
SIVP cannot control the growth in the obd mutant (schematics,
Fig. 6G–I). The inner basket and its connections to the outer basket
are visible (Fig. 6B–F′).
Using our staging series, we observe common features in SIVP
formation in individual obd mutant embryos but they were ac-
companied by excessive vascular growth (Fig. 7 and Movie 4). The
ﬁrst SIVP vessel sprouts precociously in obd mutants (Fig. 7A–A′)
as compared to wild-type embryos (Fig. 3A–A′). The fast expansion
of the plexus is driven by increased and constant sprouts from the
inner connecting vessels and new sprouts from the PCV (Fig. 7C–
D′). Filopodia are present during the entire SIVP expansion, with
Fig. 4. Quantitative analysis of SIVP vessel angiogenesis in wild-type embryos. (A) Measurement of the area of the vessel coverage over the yolk at two different stages.
(B) The extent of migration of the SIVP outer basket was tracked from 30 to 76 hpf in multiple embryos. The average values were calculated and plotted in a graph. (C) The
mean number of compartments per SIVP was calculated at 55 hpf. Scale bars represent 100 mm.
M. Goi, S.J. Childs / Developmental Biology 409 (2016) 114–128120thin processes developing from pre-existing vessels even at 76 hpf.
Signiﬁcantly, no pruning events were observed (Fig. 7E–H′).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.10.017.
The SIVP expands on the yolk more than wild-type (compare
Figs. 7I and 4A) and measured 37,268 76341 mm2 (n¼24 em-
bryos), signiﬁcantly larger than wild-type embryos at 33,128 þ/
6591 mm2 (po0.05; Fig. 9A). Moreover, there is a striking differ-
ence in small angiogenic vessels forming compartments. obd
mutants show a mean of 30 compartments versus 11 compart-
ments present in wild-type embryos (po0.01, Fig. 7J).A previous study demonstrates that the absence of Sema-Plex-
inD1 signaling in obd mutants results in more endothelial cells
within the ISV sprouts and in more tip cells compared to wild-type
embryos (Zygmunt et al., 2011). Here, we observed a higher number
of sprouts to form the SIVP in obd mutants and by analyzing pro-
liferative cells during SIVP expansion we detected proliferation of
both tip and stalk cells in plexinD1 morphants (Fig. S3; Movie 5).
This conclusion is also supported by EdU staining (Fig. S3).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2015.10.017.
Fig. 5. Both leading and trailing cells proliferate during migration. (A–H) Confocal micrographs of a time-lapse of a Tg(ﬂi:EGFP)y7 embryo. (A′–H′) Enlargements are shown
below each frame. (A′–D′) Red and yellow circles indicate two proliferating leading cells from about 45 to 46 hpf. (E′–H′) Magenta and blue circles indicate two dividing
trailing cells from about 49–50 hpf. (I) Red EdU staining on Tg(ﬂi:EGFP)y1 embryo at 48 hpf. (J–K) Boxes indicate the position of the enlargements from image I. J indicates a
trailing cell and K a leading cell. (J′–K″′) Merge of enlargement of boxes J and K. Endothelial cells are marked green and proliferating nuclei, red. White arrowheads indicate
SIVP proliferating cells. Scale bars represent 100 mm.
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We next wanted to understand the growth factor and guidance
cues that set up the migration and pattern of the SIVP. Given that
the development of arterial vascular beds is controlled by a
number of growth factors and that venous sprouting requires a
different set of cues, we tested whether any of these factors areimportant in SIVP formation. We undertook a screen using small
molecule inhibitors adding them in E3 embryo medium at 24 hpf
before the ﬁrst sprouts form the ﬁrst SIVP vessel.
We found several signaling pathways had no effect on SIVP
development. While Notch signaling controls angiogenic cell be-
havior in the intersegmental arteries (Siekmann and Lawson,
2007), inhibiting Notch with 100 mM DAPT or 25 mM LY411575 did
Fig. 6. obd mutants have a variable SIVP pattern and SIVP overgrowth. Depth-coded confocal stacks of SIVP development in two individual embryos (A–C′ and D-F′) of
obdfov01b; Tg(ﬂi:EGFP)y1 line from 2 to 4 dpf showing variability in SIVP pattern. The border of the inner vascular basket is indicated by white arrowheads. Shared vessels
between the inner and outer basket are indicated by red arrowheads. Scale bars represent 100 mm. (G–I) Schematics of SIVP phenotype in wild-type (Fig. 2C), obd 1 (Fig. 6C)
and obd 2 (Fig. 6F) embryos at 4 dpf.
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documented phenotypes such as an upwardly curled body axis
suggesting the drugs were functional (Fig. S5). Thus Notch activity
does not appear to be involved in SIVP formation.
Sonic hedgehog signaling also appeared to play no role in SIVP
development. shh, expressed in the early mouse gut endoderm,
plays a role in gut, liver, villus and smooth muscle morphogenesis
(Ramalho-Santos et al., 2000; Wallace and Pack, 2003; Zeng and
Childs, 2012). Moreover, Shh induces the expression of vegfaa in
the somites, which is important for ISV development (Lawson
et al., 2002). However, blocking shh with 50 mM cyclopamine, a
hedgehog receptor inhibitor (Fig. S4) did not alter SIVP develop-
ment suggesting that Shh does not control SIVP formation. We
veriﬁed the function of cyclopamine by looking for hemorrhage
and curly-down body axis in drug treated embryos as shown in
Lamont et al., 2010 (Fig. S5–6).
Platelet-Derived Growth Factor (Pdgf) also appears to play no
role in SIVP growth or patterning. Pdgf signaling promotes ISV
angiogenesis (Wiens et al., 2010). Pdgf is a potent mitotic inducer
with two receptors, Pdgfrα and Pdgfrβ, both inhibited by 0.25 mM
Pdgfr Inhibitor V (Wiens et al., 2010). We found that Pdgfr In-
hibitor V treated embryos showed a lack of inner compartmentformation in the SIVP, an identical phenotype as seen for Vegfr2
inhibition suggesting a possible function of Pdgf signaling in SIVP
development (Fig. S4). However, Pdgfr Inhibitor V (also called Ki
11502) has reported activity on the Vegfr2 (Nishioka et al., 2008)
and thus we tested a second Pdgf receptor inhibitor (imatinib).
50 mM imatinib did not affect SIVP development (Fig. S4). This
observation suggests that the absence of internal vessels detected
with Pdgfr Inhibitor V exposure is caused by its activity on Vegfr2
rather than by the speciﬁc action on Pdgfr. This conclusion is also
supported by the presence of CtAs in imatinib treated embryos
and their absence when Pdgfr Inhibitor V was used (Fig. S6).
On the other hand, two pathways strongly affected SIVP de-
velopment. The Bmp pathway is important for gut smooth muscle
formation (Kedinger et al., 1998; Roberts et al., 1998), and is also
necessary for formation of a closely related venous vessel bed in
zebraﬁsh, the CVP (Wiley et al., 2011). bmp4 is expressed in the gut
during SIVP development while alk2 transcript is detectable in the
axial vessels (Fig. S1) (Roman et al., 2002; Zeng and Childs, 2012).
50 mM DMH1 (inhibitor of the Bmp type I receptor Alk2; Hao et al.,
2010) caused a reduction of the SIVP expansion but did not ablate
or disrupt the pattern of the SIVP, suggesting that Bmp plays a role
in outgrowth but not patterning (Fig. 8C–C′). To test that this dose
Fig. 7. The obd SIVP shows precocious development, constant cue search, aberrant migration and higher number of compartments. (A–H) Confocal micrographs from a time-
lapse of a developing obdfov01b; Tg(ﬂi:EGFP)y1 SIVP. (A′–H′) Enlargements of images in A–H. (A′) White arrowheads indicate the precocious development of the SIVP vessels. (B
′) White arrows point to some of the developing compartments. (C′–D′-E′-F′) Red arrowheads mark the presence of constant ﬁlopodial extension and aberrant migration and
sprouting. (G’-H’) Red arrows indicate the formation of new ﬁlopodia scanning the environment. No pruning events are visible. (I–J) Quantitative analysis of obd SIVP vessel
angiogenesis. (I) Measurement of the area of the vessel coverage over the yolk of wild-type and obd mutant embryos at 55 hpf. J) The mean number of compartments per
SIVP in wild-type and obd mutant embryos was calculated at 55 hpf. The average values were calculated and plotted in a graph. **¼pr0.01 and ***¼pr 0.001 by the
Student's T-Test. Scale bars represent 100 mm.
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embryos to DMH1 from 4 hpf observing dorsalizing effects as
shown in Hao et al., 2010 (Fig. S5). Moreover, injection of bmp4
morpholino phenocopied the treatment with DMH1 suggesting
that Bmp4 is a positive cue for growth (Fig. 8D–D′). Using our
quantitative analysis, we found a decreased area, decreased
number of endothelial cells, but no signiﬁcant difference in the
number of basket compartments with Bmp inhibition (Fig. 8L–N).
Vascular endothelial growth factors are critically important in
blood vessel formation (Liang et al., 2001). For this reason we in-
vestigated the role of VegfA on SIVP formation treating the em-
bryos with a Vegfr2 inhibitor (DMH4, Hao et al., 2010). If 50 mM
DMH4 is applied at 4 hpf, there is a complete lack of SIVP for-
mation (Fig. 9A–A″). However, when the drug is applied from
24 hpf, embryos show an absence of SIVP compartments, but still
have a lumenized, external SIVP vessel present (Fig. 8E–E′).
Moreover, continued drug exposure through 3 dpf did not allow
any additional sprouting (data not shown). Proper patterning is
not recovered after removing the drug, suggesting there is a cri-
tical early window for sprouting from the vein to form the SIVP.
These data suggest that the program for development of the ﬁrst
SIVP sprout to form the outer vessel of the SIVP is determined
before 24 hpf and together with the formation of derivative
sprouts, it is Vegf-dependent.
Using our quantitative analysis on 50 mM DMH4 treated em-
bryos from 24 hpf, we found no change in area of the SIVP, but
there was a strongly decreased number of endothelial cells, and a
large decrease in the number of basket compartments (Fig. 8L–N).
These data suggest that expansion and migration of the ﬁrst, outer
SIVP vessel is not Vegf-dependent at later timepoints. As a positive
control, we showed that other angiogenic beds are inhibited withthis drug; the central arteries in the head (CtAs) sprout at the same
time as the SIVP and are not present in DMH4 treated embryos
(Fig. S6). In support of the Vegf playing a role in SIVP development,
vegfaa and vegfab (the two vegfA isoforms) are expressed in the
podocytes of the pronephric ducts adjacent to the developing SIVP
and vegfr2 is expressed by SIVP endothelial cells (Fig. S1). Others
have also reported that vegfA is expressed in the developing pro-
nephros/podocytes (Liang et al., 2001; Majumdar et al., 2000).
Morpholino knockdown of vegfaa does not show SIVP phenotype
but knockdown of vegfab morpholino strongly reduces the SIVP
basket (Fig. 8F–G′). Double knockdown of vegfaa and vegfab does
not show an additional phenotype (Fig. 8H–H’).
Since inhibition of Vegf or Bmp signaling both interfere with
SIVP formation, this suggests that both pathways contribute to its
development. We next wanted to understand whether Vegf and
Bmp work in parallel pathways to inﬂuence SIVP angiogenesis. We
inhibited both pathways simultaneously using either a single drug
that blocks both receptors (dorsomorphin) or two drugs that are
speciﬁc for either receptor (DMH4 and DMH1). Double knockdown
eliminates the SIVP and suggests that Vegf and Bmp act in parallel
and have partially overlapping roles in promoting SIVP sprouting
and growth (Fig. 8I–J′). The Mek/Erk pathway is also downstream
of Bmp and Vegf pathways as shown in zebraﬁsh CVP develop-
ment. We inhibited Mek-1 and -2 through use of 30 mM SL327
(Wiley et al., 2011) and found that the SIVP is also almost com-
pletely eliminated (Fig. 8K–K′). As a positive control, we show that
the drug also disrupts CVP formation (Wiley et al. 2011; Fig. S6).
Thus our screen for growth factor pathways affecting SIVP de-
velopment suggests that Vegf and Bmp act in parallel to promote
SIVP development, with Vegf promoting initial sprouting and in-
ner vessel formation and Bmp promoting outgrowth over the yolk.
Fig. 8. Vegf and Bmp redundantly control SIVP growth. (A–K) Phenotype of embryos treated with small molecule inhibitors from 24 hpf to 48 hpf or morpholinos.
(A) Untreated control embryo (B) DMSO treated control embryos. (C) 50 mM DMH1 treated embryo, an inhibitor of the Bmp type I receptor Alk2. (D) bmp4 morphant.
(E) 50 mM DMH4 treated embryo, a Vegfr2 inhibitor. (F) vegfaamorphant. (G) vegfabmorphant. (H) vegfaa and vegfab double morphants. (I) DMH4 and DMH1 treated embryo
at 25 mM each. (J) 50 mM dorsomorphin. (K) 30 mM SL327, a Mek-1/Mek-2 inhibitor. (A′–K′) Schematics corresponding to images above (A–K). Red brackets indicate the
reduced expansion of the SIVP and asterisks mark the absence of SIVP internal vessels and ISVs. Scale bar represents 100 mm. (L–N) Measurement of the average area of the
vessel coverage over the yolk, number of compartments or number of cells at 48 hpf for wild-type, DMH1 treated and DMH4 treated embryos. **¼pr0.01 and
***¼pr0.001 using ANOVA.
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Notch, Sonic Hedgehog and Pdgf, appear not to be important for
formation of this vessel bed.
3.9. obd embryos have decreased sensitivity to Vegf inhibition
obd mutants have abnormal Vegf signaling with decreased
sFlt1 expression and therefore higher Vegfr2 activity (Zygmunt
et al., 2011). In order to understand this relationship during SIVP
development, we blocked Vegf signaling in wild-type and obd
mutant embryos using DMH4 from 4 or from 24 hpf (Fig. 9). Whenwe inhibit Vegfr2 action in wild-type embryos from 4 hpf we see
signiﬁcantly decreased sprouting from the PCV, with only one
aberrant sprout from the duct of Cuvier persisting during this
window. This sprout was limited in extension (Fig. 9A–A″). As
previously noted, when treated from 24 hpf with DMH4, wild-type
embryos only show the external SIVP vessel with no compart-
ments or connections to the supraintestinal artery (Fig. 9B–B″). In
obd mutant embryos when we treat with DMH4 from 4 hpf we
observe some sprouts from the PCV when there are none in wild-
type treated embryos. While these sprouts do not migrate ex-
tensively over the yolk, they are still present during Vegf blockade,
Fig. 9. obdmutants are less sensitive to Vegf inhibition. Phenotype of wild-type (A–B″) and obd (C–D″) embryos treated with 50 mM DMH4. (A–A″) A Tg(ﬂi:EGFP)y1 wild-type
was treated from 4 hpf and lacks the ﬁrst SIVP sprouts. White arrowheads point to the attempted sprouts from along the PCV. White arrows indicate an aberrant sprout from
the duct of Cuvier. (B–B″) A Tg(ﬂi:EGFP)y1 wild-type was treated from 24 hpf which stops the formation of SIVP vascular compartments. Asterisks mark the absence of the
internal vessels and dysmorphic ISVs. The expansion of the external vessel above the yolk ball is not affected by the inhibition. (C–C″) obdfov01b; Tg(ﬂi:EGFP)y1 treated embryo
from 4 hpf shows some sprouts are present. White arrowheads indicate blocked sprouts from along the vein. White arrows point to irregular sprouts from the duct of Cuvier.
(D–D″) obdfov01b; Tg(ﬂi:EGFP)y1 embryo treated from 24 hpf. Red arrowheads point to residual sprouts. Scale bars represent 100 mm.
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″ and C–C″). Drug treatment from 24 hpf has a similar effect on obd
embryos in reducing, but not completely eliminating sprouts
(Fig. 9D–D″). In contrast, DMH4 treatment from 24 hpf in wild-
type embryos allowed only the ﬁrst external SIVP vessel to de-
velop properly (Fig. 8 and Fig. 9B–B″). In wild-type embryos,
morpholino knockdown of vegfab but not vegfaa inhibits SIVP
development (Fig. 8). In obdmutants, vegfab also appears to be the
more important vegfA gene for SIVP development (Fig. S7).
obd mutants are also sensitive to Bmp signaling inhibition.
Treatment with DMH1 reduced the SIVP expansion in obd em-
bryos (Fig. S7) and double inhibition of Vegf and Bmp pathway
drastically reduces SIVP development in obd mutants although
there are a few residual sprouts that are not inhibited (Fig. S7).
Inhibition of Mek/Erk signaling also reduces, but not completely
eliminates, SIVP development (Fig. S7).4. Discussion
The intent of this project was to understand the anatomical and
molecular basis of visceral venous plexus formation. The devel-
oping SIVP is easily visible and accessible to manipulation and is a
popular model for pro- and anti-angiogenesis drug screening
(Chan et al., 2012; Kuo et al., 2011; Raghunath et al., 2009; Ser-
bedzija et al., 1999) and cancer models (Nicoli et al., 2009, 2007;
Nicoli and Presta, 2007). Some of our results, however call into
question the use of this model for drug screening without taking
into account that this plexus responds to a different set of mole-
cular cues than those that inﬂuence arterial vessel bed
development.
The SIVP is directly above YSL, an important early develop-
mental signaling center that absorbs nutrients from the yolk and
transports them to the embryo (reviewed in Carvalho and Hei-
senberg, 2010). Moreover, the YSL expresses genes required in
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before the embryo is capable of sustaining feeding and absorption.
The zebraﬁsh SIVP is structurally and functionally homologous to
the murine vitelline veins, transporting nutrients from the mo-
ther's body through the yolk sac to the developing embryo.
Previous observations suggested that the duct of Cuvier as the
source and origin of the ﬁrst SIVP sprout (Isogai et al., 2001; Nicoli
and Presta, 2007), however, with the use of time-lapse imaging we
demonstrate that the source of angioblasts is actually the PCV.
These cells sprout from different positions along the axial vein and
migrate ventrally to join with each other. They then form a basket
that runs from the yolk to the posterior end of the yolk extension.
During the revision of this paper, both (Lenard et al., 2015) and
(Nicenboim et al., 2015) published a similar analysis of SIVP for-
mation. These two research teams suggest the SIVP is derived from
the PCV. Nicenboim and colleagues also used lineage tracing to
demonstrate that the SIVP is generated from asymmetric cell di-
visions from the posterior cardinal vein.
The intersegmental vessels are a well characterized model for
angiogenesis because of their simplicity and stereotypical pat-
terning. These primary angiogenic vessels sprout from both sides
of the dorsal aorta, grow dorsally following the vertical boundary
between somites and join together into the dorsal longitudinal
anastomotic vessel dorsal to the neural tube (Childs et al., 2002).
However, many mammalian vessel beds develop from non-ste-
reotypical vascular plexuses, more similar to SIVP formation. In
this type of angiogenesis, the initial vascular plexus contains more
vessels than necessary and is subsequently remodeled into an ef-
ﬁcient vascular network. The SIVP is venous in its initial formation,
which also distinguishes it from the ISVs that initially sprout from
the aorta (Isogai et al., 2003). The variability in pattern among
embryos in the SIVP suggests that angioblast migration does not
follow a pre-determined spatial pattern of molecular cues. How-
ever, given that we were able to obtain a staging series with
characteristic growth parameters, this suggests there is some
control of migration and pattern. In this way, the SIVP is similar to
the midbrain vasculature, which also does not develop with a ﬁxed
pattern but resolves into a patterned network (Chen et al., 2012).
In addition to the previously described superﬁcial SIVP, we
observe that there is an inner, smaller and denser vascular plexus
underneath the earlier forming SIVP basket. The inner SIVP basket
wraps the anterior part of the digestive system and has the same
morphology as the superﬁcial SIVP on the yolk with an outer
vessel and compartments branching from it. We were able to see
common vessels between the two baskets suggesting shared blood
ﬂow. Since the outer basket regresses during later embryonic de-
velopment, this suggests that the inner basket gradually takes over
from the outer basket as the yolk depletes, and is the vascular bed
specialized in absorbing and distributing nutrition from the gut.
The developing gut is a source of Bmp that likely promotes the
development of the adjacent SIVP (Zeng and Childs, 2012).
During SIVP development we were able to pinpoint key com-
mon steps. The presence of ﬁlopodia and lamellipodia suggests
active migration of angioblasts and an active scan of the en-
vironment for attractive or repulsive cues during migration. We
observed vegfA expression in the pronephric ducts and bmp4 in
the gut, and both are required for SIVP angiogenesis. Interestingly,
we also observed remodeling and pruning events similar to those
seen in the mature midbrain vasculature, which are of critical
importance for the efﬁciency of circulation (Chen et al., 2012).
Lenard et al. (2015) also recently showed the pruning process in
the SIVP follows the opposite sequence of events that occur in
anastomosis (Lenard et al., 2015).
In order to be able to compare SIVP development in mutants,
we measured quantitative features of SIVP development. The
speed of migration of the leading sprouts of the SIVP was 4.5 mm/hwhich is slightly slower than what is observed for cultured pri-
mary endothelial cells that migrate up to 15 mm/h (Vitorino and
Meyer, 2008). In comparison, ISV migration in zebraﬁsh has an
average speed of 17 mm/h that steadily decreases over 3 h post-
sprouting, then increases again to around 10 mm/h at 5 hours post-
initiation (Shirinifard et al., 2013). Thus the SIVP migrates slightly
slower than other vessel types in vitro and in vivo.
We also observed that both leading (tip) and trailing (stalk)
cells proliferate during SIVP expansion, which contrasts to the ISVs
where tip but not stalk cells proliferate (Siekmann and Lawson,
2007), or mouse retinal vessels where stalk but not tip cells pro-
liferate (Gerhardt et al., 2003). We did not observe any direction-
ality in the plane of cell division during this process.
We were curious to look for a role of PlexinD1 in SIVP devel-
opment. plexinD1 is highly expressed in normal vascular en-
dothelium. Activation of PlexinD1 causes ﬁlopodial collapse to halt
angioblast migration in the direction of the repulsive cue. obd
mutants show exuberant vessel growth in both the ISVs and SIVP,
highlighting a role for PlexinD1 in suppressing both arterial and
venous sprouting and migration. We observed increased migration
and number of smaller vessels making compartments as well as
reduced pruning events in obd mutants. obd mutants have an in-
creased number of endothelial cells in the ISVs (Zygmunt et al.,
2011) as well as in the SIVP. Thus, PlexinD1 plays a similar role in
both ISV and SIVP development to control spatial and temporal
sprouting and vascular patterning. Given the relationship between
PlexinD1 and Vegf, it is not surprising that obd mutants are also
less sensitive to Vegf blockade during SIVP development.
We were surprised that when we explored the roles of known
angiogenic growth factors, only Vegf and Bmp pathways play a
role in SIVP development, while Shh, Notch and Pdgfr were dis-
pensable. Vegf inhibition blocks all formation of the SIVP if ad-
ministered at early timepoints. Vegf is also necessary for inner
compartment formation, most likely through its role in promoting
proliferation as the number of SIVP cells is substantially decreased
in the absence of Vegf signaling. It is interesting that the outer-
most SIVP vessel still migrates to a normal position on the yolk
when we inhibit Vegfr2 later in development. This suggests that
migration of the SIVP over the yolk is not controlled by Vegf
signaling.
On the other hand, Bmp, which promotes ventral sprouting
during CVP development (Wakayama et al., 2015; Wiley et al.,
2011), is expressed in the adjacent gut during SIVP development
(Zeng and Childs, 2012). The SIVP has strongly reduced expansion
in the absence of Bmp signaling. Thus, analogous to its role in the
CVP, Bmp promotes migration or outgrowth of the SIVP. However
unlike the CVP, Bmp is not necessary for initial sprouting. Vegf and
Bmp therefore play distinct but partially overlapping roles in
patterning this venous structure suggesting a partial redundancy.
The double inhibition of Vegf and Bmp pathway completely blocks
the formation of the SIVP conﬁrming that the two pathways are
necessary and sufﬁcient to control the proper formation of this
venous bed (see schematics in Fig. 10). Vegf is not involved in CVP
development, while it is involved in SIVP development, which is a
distinction between the patterning of these two vessel beds.
A molecular connection between the Vegf and PlexinD1 path-
ways has been reported via the induction of sﬂt1 expression by
PlexinD1 (Zygmunt et al., 2011) during ISV formation. sFlt1 se-
questers VegfA reducing the activation of the signaling cascade
downstream of Vegfr2. Since loss of PlexinD1 leads to decreased
inhibitory decoy receptor expression and therefore increased
VegfA availability to signal through Vegfr2, we reasoned that
vessel overgrowth in obd mutants should be sensitive to Vegfr2
inhibition. Interestingly, Vegfr2 inhibition was less effective in obd
mutants as compared to wild-type embryos, perhaps reﬂecting the
higher concentrations of available VegfA to bind to Vegfr2.
Fig. 10. Model of SIVP development. In cross section and lateral view at early stages (A–B), Vegf is secreted by the pronephric ducts (green) while Bmp is secreted by the
intestine (brown). VegfA (green arrows), promotes sprouting of cells to form the SIVP from the posterior cardinal vein (pcv, blue). Bmp4 expressed in the gut (brown arrows),
promotes the migration of angioblasts from the vein. (C) At later stages, honeycomb-structured vascular compartments form. (D) The mature plexus comprises a remodeled
inner and outer basket. Abbreviations: da (red): dorsal aorta; pd (green): pronephric duct; pcv (blue): posterior cardinal vein; (brown): gut; (yellow): yolk.
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tion, the use of the SIVP as a system to test pro- and anti-angio-
genic drugs or cancer angiogenesis needs to be carefully con-
sidered. Our study will be a useful tool to understand the speciﬁc
action of new drugs provided they are considered within the
context of wild-type development. For instance, patterning is
highly variable, and studies that use growth parameters need to
include enough embryos to fully assess variability in the wild-type
and experimental population. Furthermore, the different sensi-
tivity of the SIVP to growth factor inhibition (insensitive to Notch,
Shh or Pdgf inhibition, but sensitive to Vegf and Bmp inhibition)
contrasts to other vascular beds. Screening for anti-angiogenic
molecules in this bed will therefore yield different targets than if
other vessel beds were studied. This could be both a strength and
weakness of the system. We propose that the developing gut
vasculature is a unique model to shed insight into novel me-
chanisms utilized in venous and organ-speciﬁc angiogenesis.Acknowledgments
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